COLDA 2019

FIND is holding a two-hour session at the Conference on Liver Disease in Africa that will cover key concepts on both HBV and HCV and include a ‘wet’ training demonstrating some of the available diagnostic technologies.

Hepatitis B (HBV) and hepatitis C virus (HCV) infections account for 1.3 million deaths per year. HBV and HCV infections can turn into a chronic disease that progresses for decades without being noticed. There are approximately 250 million people living with HBV and 70 million people living with HCV and only 2 out of 10 of those who are infected are aware of their disease. Insufficient coverage of viral hepatitis testing services is a major barrier to increase access to care and eventual elimination of the disease. HBV and HCV testing services can be substantially improved by expanding the use of existing, and introducing new, diagnostic tools.

Date and time: 6 September 2019, 9:30–11:30 AM
Venue: Triumph Luxury Hotel, Cairo, Egypt – Room: Iceland

Friday, 6 September 2019 at 9:30 
Time Topic Presenter
5 min Opening Elena Ivanova, FIND
10 min How to test for Hepatitis B virus infection:
–Testing approaches
Testing tools: laboratory-based and point-of-care
Cynthia Tamandjou, Stellenbosch University, South Africa
10 min How to test for Hepatitis C virus infection:
–Testing approaches
–Testing tools: laboratory-based and point-of-care
Elena Ivanova, FIND
10 min Best practices in conducting point-of-care assays: how to ensure high-quality testing? Ryan Ruiz, FIND
80 min Interactive session: live demonstration of point-of-care HCV and HBV assays FIND and test manufacturers

List of technologies for the live demonstration:

–RDT for HBsAg detection: SD Bioline HBsAg test (Abbott Raid Diagnostics, US)
–RDT for HCV Ab detection: OraQuick HCV assay (Orasure Technologies, US), SD Bioline HCV assay (Abbott Rapid diagnostics, US)
–Multiplex RDTs: triple HBV/HCV/HIV detection (Biosynex, France)

–Xpert HCV Fingerstick assay and Xpert HBV assay (Cepheid, US)
–GeneDrive HCV ID assay (GeneDrive, UK)
–TrueNAT HCV assay and HBV assay (Molbio Diagnostics, India) – late-stage prototypes
–Samba II HCV fingerstick assay (Diagnostic for the real World, UK) – late-stage prototype